Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

45
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
45
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

55
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
55
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

53
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
53
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

14
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
14
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

27
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
27
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

20
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
20

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Microbiota dysbiosis influences immune system and muscle pathophysiology of dystrophin deficient mice.

EMBO molecular medicine·2026
Same author

Withdrawal Note: Microbiota dysbiosis influences immune system and muscle pathophysiology of dystrophin-deficient mice.

EMBO molecular medicine·2026
Same author

Organoid models through the lens of metabolomics: a systematic review of experimental applications and analytical approaches.

The Analyst·2026
Same author

Micro- and Nanoplastics as Disruptors of Digestive and Hepatopancreatic Homeostasis: Insights into the Plastic-Gut-Liver Axis.

International journal of molecular sciences·2026
Same author

A longitudinal comparative analysis of serum metabolomic signatures in children with SARS-CoV-2 infection and MIS-C.

Communications medicine·2026
Same author

No Difference in Pain Levels and Functional Outcomes After Primary Hip Arthroscopy With Labral Repair Versus Labral Augmentation at Minimum 1-Year Follow-Up.

Arthroscopy, sports medicine, and rehabilitation·2025

相关实验视频

Updated: May 10, 2025

Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis
07:11

Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis

Published on: November 10, 2023

2.2K

双重权衡贝叶斯模型组合用于代谢学数据描述和预测.

Jacopo Troisi1,2,3, Martina Lombardi1,2, Alessio Trotta1,2

  • 1Theoreo srl, Via degli Ulivi 3, 84090 Montecorvino Pugliano, SA, Italy.

Metabolites
|April 25, 2025
PubMed
概括

一个新的双重贝叶斯集群机器学习 (DW-EML) 模型增强了代谢学数据分析. 这种人工智能工具为疾病诊断和精准医学应用提供了更高的准确性和可靠性.

关键词:
贝叶斯模型是贝叶斯模型.诊断工具 诊断工具 诊断工具整体机器学习 整体机器学习代谢生物组的代谢生物组精准医学是一门精准医学.

更多相关视频

A Strategy for Sensitive, Large Scale Quantitative Metabolomics
14:18

A Strategy for Sensitive, Large Scale Quantitative Metabolomics

Published on: May 27, 2014

20.9K
Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics
11:02

Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics

Published on: November 29, 2024

406

相关实验视频

Last Updated: May 10, 2025

Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis
07:11

Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis

Published on: November 10, 2023

2.2K
A Strategy for Sensitive, Large Scale Quantitative Metabolomics
14:18

A Strategy for Sensitive, Large Scale Quantitative Metabolomics

Published on: May 27, 2014

20.9K
Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics
11:02

Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics

Published on: November 29, 2024

406

科学领域:

  • 计算生物学 计算生物学
  • 生物信息学是一种生物信息学.
  • 机器学习 机器学习

背景情况:

  • 代谢学提供了对生物过程和疾病状态的洞察.
  • 代谢学在疾病诊断和精准医学中的作用越来越大.
  • 在代谢学医学应用中需要强大的AI工具.

研究的目的:

  • 介绍一个新的双重贝叶斯集团机器学习 (DW-EML) 模型.
  • 提高对代谢学数据的分类和预测准确度.
  • 在医疗应用中提高可靠性和准确性.

主要方法:

  • 开发了一个DW-EML模型,集成多个分类器.
  • 采用基于交叉验证准确性和分类信心的双重加权投票方案.
  • 将模型应用于公开可用的代谢学数据集.

主要成果:

  • 与传统方法相比,DW-EML模型显示出更高的性能.
  • 在精度和预测能力方面表现优于部分最小平方差分分析 (PLSDA).
  • 在各种数据集上得到验证,包括危急疾病,伤寒携带和卵巢癌检测.

结论:

  • DW-EML是用于代谢数据分析的强大可靠工具.
  • 提供了改进诊断和预后应用的潜力.
  • 为个性化和精确医学的进步做出贡献.